Hantech Bio-Technology Co., Ltd. (1294) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hantech Bio-Technology Co., Ltd. (1294:TWSE), powered by AI.

Current Price
$80.00
Sector
Consumer Defensive
What is the Hantech Bio-Technology Co., Ltd. stock price forecast?

Hantech Bio-Technology Co., Ltd. is currently trading at $80.00. View real-time AI analysis on Alpha Lenz.

What is Hantech Bio-Technology Co., Ltd. insider trading activity?

View the latest insider trading data for Hantech Bio-Technology Co., Ltd. on Alpha Lenz.

What is Hantech Bio-Technology Co., Ltd.'s P/E ratio?

View Hantech Bio-Technology Co., Ltd.'s valuation metrics on Alpha Lenz.

Hantech Bio-Technology Co., Ltd.

TWSE · 1294
NT$80.00+0.90(+1.14%)
Ask about Hantech Bio-Technology Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Hantech Bio-Technology Co., Ltd.'s ROE is 16.9%. Explore profitability and growth together.

Ask for details

Company Overview

Hantech Bio-Technology Co., Ltd. is a biotechnology company specializing in the manufacture and sale of health supplement products and functional beverages. Its core business revolves around developing dietary supplements offered in gel, liquid, and powder forms—often delivered via innovative pouch packaging including patented aluminum foil and retort designs. Serving both OEM and ODM needs, Hantech provides tailored solutions for partners seeking bespoke health food products, such as collagen drinks, lutein supplements, iron-infused drinks, pearl powder, and Guilu (tortoise shell and deer antler) essence. Established in 2007 and headquartered in Yuanlin City, Taiwan, the company adheres to international standards like ISO22000 and GMP, ensuring high product quality. Hantech’s offerings impact the consumer staples sector, addressing growing market demand for nutraceuticals and functional foods within Taiwan and exporting to China, Southeast Asia, America, and beyond. Its market significance is marked by a comprehensive portfolio of packaged health foods, innovative delivery systems, and a focus on research-driven product development.

SectorConsumer Defensive
IndustryPackaged Foods
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$778.54MRevenue
0.00Shares Out
0Employees

Margins

37.11%Gross
27.58%EBITDA
22.29%Operating
22.22%Pre-Tax
17.86%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

37.04%Rev 3Yr
23.90%Rev 5Yr
44.57%Op Inc 3Yr
18.92%Op Inc 5Yr
44.75%Net Inc 3Yr
20.10%Net Inc 5Yr

Returns

12.17%ROA
16.89%ROE
15.40%ROIC

Financial Health

NT$249.40MCash & Cash Equivalents
NT$84.70MNet Debt
40.14%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Hantech Bio-Technology Co., Ltd. (ticker: 1294) is a company listed on TWSE in the Consumer Defensive sector (Packaged Foods).

The current price is 80 with a P/E ratio of -x and P/B of -x.

ROE is 16.89% and operating margin is 22.29%. Annual revenue is $779M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Hantech Bio-Technology Co., Ltd. (1294) Stock Forecast 2026 $80.00 — Price, Financials & Analyst Targets | Alpha Lenz